Moreover, in mice implanted with Ccl2-IL1Ra constructs for 28-weeks, the arthritis clinical scores were similar to those animals challenged with K/BxN serum after one week of implantation, underscoring the long-term activity of these constructs in vivo (Figure 4I). This evidence concerns the gene IL1RN and arthritic joint disease.